Life Choice L-Arginine and L-Ornithine
Life Choice L-Arginine and L-Ornithine, NPN 80030145: natural health product licensed in Canada. Medicinal ingredients: Acide (S)-2,5-diaminopentanoïque, L-arginine.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide (S)-2,5-diaminopentanoïque | 250 mg | Not calculated |
| L-arginine | 500 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Microcrystalline cellulose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Amino acids for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
If seal around cap is broken or missing, do not use. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have a renal/kidney disease or if you are following a low protein diet. Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity. Consult your health care practitioner prior to use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners. Do not use if you have had a heart attack/myocardial infarction. Some people may experience gastrointestinal discomfort (such as diarrhea). Consult your health care practitioner prior to use if you have hyperonithinaemia-hyperammonaemia-homocitrullinuria (HHH) syndrome. Do not use if you have a gyrate atrophy of the choroid and retina.
Product record
- Other names
- Doctor's Choice A&O, Doctor's Choice L-Arginine and L-Ornithine, Life Choice A&O
- Licence holder
- Life Choice Ltd.
- NPN or DIN-HM
- 80030145
- Status
- Active licence
- Licence date
- 4 March 2012
- Revision date
- Not provided
- Form
- Capsule végétale
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80030145
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Life Choice L-Arginine and L-Ornithine: composition and ingredients”, https://compoatlas.com/en/supplements/canada/80030145-life-choice-l-arginine-and-l-ornithine, updated 4 March 2012.